Company · CVS
CVS Health Corporation
Name as listed on its exchange; filed with the SEC as CVS HEALTH Corp.
Nasdaq's symbol directory lists CVS on the New York Stock Exchange as “CVS Health Corporation Common Stock”.
In the 12 months to Nov 19, 2026: insiders bought on 1 occasion ($2.0M); insiders sold on 4 occasions ($323.7M); 1 filing by holders of 5% or more; 12 congressional trade disclosures; 4 company reports (Form 8-K, since May 26, 2026).
All insider filings at the SEC · Appeared in No. 51, No. 47, No. 44
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Larry Robbins sold $317.5M
- Tilak Mandadi, EVP, Chief Exp & Tech Officer sold $6.2M
- Prem S. Shah, EVP and Group President bought $2.0M
Every trade (5)
- BUYPrem S. Shah, EVP and Group President bought $2.0M
- SELLLarry Robbins sold $34.6M
- SELLLarry Robbins sold $95.5M
- SELLLarry Robbins sold $187.3M
- SELLTilak Mandadi, EVP, Chief Exp & Tech Officer sold $6.2M
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- Dodge & Cox 3.9%
Congress · STOCK Act
The Althing
Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.
- Rohit Khanna (D-CA17): Sale $15,001 - $50,000
- Rohit Khanna (D-CA17): Sale $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Purchase $1,001 - $15,000
- Alan Armstrong (R-OK): Purchase $1,001 - $15,000
- Michael T. McCaul (R-TX10): Purchase $15,001 - $50,000
- John Boozman (R-AR): Purchase $1,001 - $15,000
- Rohit Khanna (D-CA17): Sale $1,001 - $15,000
- Michael T. McCaul (R-TX10): Sale $15,001 - $50,000
- Dwight Evans (D-PA03): Sale $1,001 - $15,000
Executive branch · OGE Form 278-T
Reported by the President
6 confirmed trades on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports
- Sale: CVS HEALTH CORP $100,001 – $250,000
- Purchase: CVS HEALTH CORP $1,001 – $15,000
- Purchase: CVS HEALTH CORPORATION $1,001 – $15,000
- Purchase: CVS HEALTH CORP $50,001 – $100,000
- Purchase: CVS HEALTH CORPORATION $100,001 – $250,000
- Purchase: CVS HEALTH CORP $15,001 – $50,000
Company reports · SEC Form 8-K
In its own words
Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.
- Regulation FD disclosure Nov 4, 2026
- Results of operations and financial condition Nov 4, 2026
- Departure or appointment of directors or officers; Regulation FD disclosure Aug 17, 2026
- Results of operations and financial condition Aug 5, 2026
Federal contracts · USAspending.gov
Federal contracts
1 contract award first obligated in the last 12 months to the company or a subsidiary it lists in its 10-K, $7.0M in total obligated as USAspending.gov lists each award when Lytir last read it. Largest first.
- Department of Health and Human Services $7.0M
Sources: SEC EDGAR (Forms 4, 144 and 8-K), USAspending.gov, OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.